METHOD OF OBTAINING RECOMBINANT VESICULAR STOMATITIS VIRUS Russian patent published in 2023 - IPC C12N15/861 

Abstract RU 2807751 C1

FIELD: biotechnology.

SUBSTANCE: method of producing recombinant vesicular stomatitis virus is described. Cells stably expressing the DNA-dependent RNA polymerase of bacteriophage T7 are transfected using a mixture of plasmid expression vectors and polyethylenimine in a DNA: polyethylenimine weight ratio of 5:1. The mentioned mixture contains four plasmid expression vectors pCAG-VSVN, pCAG-VSVP, pCAG-VSVL and pCAG-VSVG, each of which encodes one of the vesicular stomatitis virus proteins N, P, L, G, respectively, under the control of the CAG promoter, and a plasmid an expression vector encoding the antigenomic sense RNA of the vesicular stomatitis virus genome under the control of the T7 promoter, in a ratio of 3:5:1:4:8 or 3:5:1:8:10. The mixture is cultivated, the culture liquid is collected, other cells are transduced with this liquid, then the cells are cultivated, and the conditioned culture liquid is collected.

EFFECT: method of obtaining recombinant vesicular stomatitis virus.

18 cl, 17 dwg, 9 ex

Similar patents RU2807751C1

Title Year Author Number
RECOMBINANT VESICULAR STOMATITIS VIRUS EXPRESSING CHIMERIC IL12-GMCSF PROTEIN 2022
  • Karabelskij Aleksandr Vladimirovich
  • Ivanov Roman Alekseevich
  • Ulitin Andrej Borisovich
RU2817896C1
GENETIC CONSTRUCT FOR GENE EXPRESSION mNG_CD4-CXCR4, RECOMBINANT PLASMID rVSV_MNG_CD4-CXCR4 AND A RECOMBINANT VESICULAR STOMATITIS VIRUS STRAIN rVSV_mNG_CD4-CXCR4, WHICH PROVIDES TARGETED VIROLYSIS OF CELLS EXPOSING HIV-1 GP120/GP41 PROTEINS TROPISM X4 ON THEIR SURFACE 2021
  • Bochkareva Mariya Dmitrievna
  • Imatdinov Ilnaz Ramisovich
  • Imatdinov Almaz Ramisovich
  • Sulgina Tatyana Vladimirovna
  • Tishin Anton Evgenevich
  • Sulgin Aleksandr Andreevich
  • Prudnikova Elena Yurevna
  • Gavrilova Elena Vasilevna
  • Maksyutov Rinat Amirovich
RU2768032C1
GENETIC CONSTRUCT FOR EXPRESSION OF mNG_CD4-CCR5 GENES, RECOMBINANT PLASMID rVSV_mNG_CD4-CCR5 AND RECOMBINANT STRAIN OF VESICULAR STOMATITIS VIRUS rVSV_mNG_CD4-CCR5 PROVIDING TARGETED VIROLYSIS OF CELLS DISPLAYING HIV-1 PROTEINS GP120/GP41 OF R5 TROPISM ON THEIR SURFACE 2021
  • Bochkareva Mariya Dmitrievna
  • Imatdinov Ilnaz Ramisovich
  • Imatdinov Almaz Ramisovich
  • Sulgina Tatyana Vladimirovna
  • Tishin Anton Evgenevich
  • Sulgin Aleksandr Andreevich
  • Prudnikova Elena Yurevna
  • Gavrilova Elena Vasilevna
  • Maksyutov Rinat Amirovich
RU2769125C1
ARTIFICIAL GENE CODING A BICISTRONIC STRUCTURE FORMED BY RECEPTOR-BINDING DOMAIN SEQUENCES OF THE GLYCOPROTEIN S OF THE SARS-COV-2 CORONAVIRUS, P2A-PEPTIDE AND GLYCOPROTEIN G VSV, RECOMBINANT PLASMID PSTEM-RVSV-STBL_RBD_SC2, PROVIDING EXPRESSION OF ARTIFICIAL GENE, AND A RECOMBINANT STRAIN OF VESICULAR STOMATITIS VIRUS RVSV-STBL_RBD_SC2, USED TO CREATE A VACCINE AGAINST SARS-COV-2 CORONAVIRUS 2020
  • Imatdinov Ilnaz Ramisovich
  • Bochkareva Mariya Dmitrievna
  • Prudnikova Elena Yurevna
  • Tishin Anton Evgenevich
  • Pyankov Oleg Viktorovich
  • Gavrilova Elena Vasilevna
  • Maksyutov Rinat Amirovich
RU2733831C1
ARTIFICIAL ECTOS_SC2 GENE ENCODING AN ECTODOMAIN OF THE SARS-COV-2 CORONAVIRUS S GLYCOPROTEIN WITH A C-TERMINAL TRIMERIZATION DOMAIN, A RECOMBINANT PLASMID PSTEM-RVSV-ECTOS_SC2, WHICH PROVIDES EXPRESSION OF THE ARTIFICIAL GENE, AND A RECOMBINANT STRAIN OF VESICULAR STOMATITIS VIRUS RVSV-ECTOS_SC2, USED TO CREATE A VACCINE AGAINST SARS-COV-2 CORONAVIRUS 2020
  • Imatdinov Ilnaz Ramisovich
  • Bochkareva Mariya Dmitrievna
  • Prudnikova Elena Yurevna
  • Tishin Anton Evgenevich
  • Pyankov Oleg Viktorovich
  • Gavrilova Elena Vasilevna
  • Maksyutov Rinat Amirovich
RU2733834C1
ARTIFICIAL GENE STBL_RBD_TRM_SC2, CODING A BICISTRONIC STRUCTURE FORMED BY THE SARS-COV-2 CORONAVIRUS GLYCOPROTEIN S RECEPTOR-BINDING DOMAIN SEQUENCES, TRANSMEMBRANE REGION, P2A-PEPTIDE AND GLYCOPROTEIN G VSV, RECOMBINANT PLASMID PSTEM-RVSV-STBL_RBD_TRM_SC2, PROVIDING EXPRESSION OF ARTIFICIAL GENE, AND A RECOMBINANT STRAIN OF VESICULAR STOMATITIS VIRUS RVSV-STBL_RBD_TRM_SC2, USED TO CREATE A VACCINE AGAINST SARS-COV-2 CORONAVIRUS 2020
  • Imatdinov Ilnaz Ramisovich
  • Bochkareva Mariya Dmitrievna
  • Prudnikova Elena Yurevna
  • Tishin Anton Evgenevich
  • Pyankov Oleg Viktorovich
  • Gavrilova Elena Vasilevna
  • Maksyutov Rinat Amirovich
RU2733832C1
VIRAL PARTICLES CONTAINING ALPHAVIRUS VECTOR AND METHOD FOR PREPARING SAID VIRAL PARTICLE 2004
  • Pazh Zhan-Kristof
RU2398875C2
METHOD FOR PRODUCING REPLICATIVE INFLUENZA VIRUS PARTICLES, CELL COMPOSITION (VERSIONS), CELL CULTURE COMPOSITION AND APPLICATION THEREOF 2005
  • De Vit Ehmmi
  • Spronken Monik I. J.
  • Faukhir Ron A. M.
  • Osterkhaus Al'Bert D. M. Eh.
RU2435855C2
DOUBLE VECTOR FOR SUPPRESSION OF HUMAN IMMUNODEFICIENCY VIRUS 2010
  • Chen Irvin
  • Ehn Don Sunn
  • Millington Mishel'
  • Bojd Maurin
  • Sajmonds Dzheffri P.
  • Breton Luis Rehndol
RU2562868C2
METHOD FOR TEMPORARY TRANSFECTION FOR PRODUCING RETROVIRUS 2016
  • Johnson, Sabine
  • Pallant, Celeste
  • Vamva, Eirini
  • Vink, Conrad
RU2749717C2

RU 2 807 751 C1

Authors

Karabelskii Aleksandr Vladimirovich

Egorov Aleksandr Dmitrievich

Gasanov Nizami Badrudinovich

Moroz Vasilii Dmitrievich

Dates

2023-11-21Published

2022-12-27Filed